Detalhe da pesquisa
1.
Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression.
Blood
; 137(26): 3604-3615, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649772
2.
PARP1 and POLD2 as prognostic biomarkers for multiple myeloma in autologous stem cell transplant.
Haematologica
; 108(8): 2155-2166, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861411
3.
Lenalidomide and Vorinostat Maintenance after Autologous Transplantation in Multiple Myeloma: Long- Term Follow-Up.
Biol Blood Marrow Transplant
; 26(1): 44-49, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31518644
4.
Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia.
Blood
; 131(8): 855-863, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29203585
5.
Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplant.
Br J Clin Pharmacol
; 86(11): 2165-2173, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32285957
6.
BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(6): 1107-1115, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30716453
7.
Daratumumab in multiple myeloma.
Cancer
; 125(14): 2364-2382, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30951198
8.
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
Cancer
; 125(3): 416-423, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30332496
9.
XRCC1-mediated DNA repair is associated with progression-free survival of multiple myeloma patients after autologous stem cell transplant.
Mol Carcinog
; 58(12): 2327-2339, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31544312
10.
Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies.
Eur J Haematol
; 102(6): 494-503, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943323
11.
Population pharmacokinetics of lenalidomide in patients with B-cell malignancies.
Br J Clin Pharmacol
; 85(5): 924-934, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30672004
12.
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma.
Br J Haematol
; 182(2): 231-244, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938772
13.
Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1.
Blood
; 127(22): 2693-700, 2016 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27009059
14.
Importin-ß and exportin-5 are strong biomarkers of productive reoviral infection of cancer cells.
Ann Diagn Pathol
; 32: 28-34, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29414394
15.
Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant.
Mol Carcinog
; 56(7): 1722-1732, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28150872
16.
A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma.
Am J Hematol
; 97(2): E54-E58, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34817872
17.
Initial genome sequencing and analysis of multiple myeloma.
Nature
; 471(7339): 467-72, 2011 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21430775
18.
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).
Biol Blood Marrow Transplant
; 22(1): 71-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26256940
19.
Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study.
Blood
; 123(12): 1826-32, 2014 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24421329
20.
Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma.
Br J Haematol
; 171(1): 74-83, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26058589